Skip to main content

Table 2 Distribution of the IC50 values and their respective confidence intervals (95%) in MCF-7, 4T1, and MCF-10A cell lines after treatment with free rhodium (II) citrate (Rh2(H2cit)4).

From: Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy

  IC50 (IC 95%)
Cell lines 24 hours 48 hours 72 hours
MCF-7 483 μM (459,2 a 507 μM) 376 μM (356,2 a 396,1 μM) 294 μM (259,9 a 332,5 μM)
4T1 440 μM (407,3 a 475 μM) 337 μM (317,3 a 357,8 μM) 271 μM (241,4 a 303,9 μM)
MCF-10A 250 μM (211,1 a 295,2 μM) 181 μM (172,3 a 190,8 μM) 123 μM (114,7 a 132,7 μM)
  1. These data refers from viability of cells after treatment with Rh2(H2cit)4 (50-600 μM) for 24, 48 and 72 hours.